Melissa Yung, CNM
Obstetrics & Gynecology · Marietta, GANPI 1598755241
Payments from drug & device makers
Across 135 payments — averaging $14.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$566
- Novo Nordisk$351
- Lilly USA, LLC$171
- AstraZeneca$130
- Abbott$102
- Xeris Pharmaceuticals, Inc.$83
- plus $561 from 17 others
What the payments were for
- Food & beverage$1,964100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 58 | $566 |
| Novo Nordisk | 18 | $351 |
| Lilly USA, LLC | 10 | $171 |
| AstraZeneca | 9 | $130 |
| Abbott | 6 | $102 |
| Xeris Pharmaceuticals, Inc. | 4 | $83 |
| GSK | 4 | $83 |
| Amgen | 4 | $65 |
| Exact Sciences | 4 | $59 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $51 |
| Dexcom, Inc. | 1 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $33 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Pfizer | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $23 |
| Shield Therapeutics Inc | 1 | $22 |
| Boehringer Ingelheim | 1 | $18 |
| Johnson & Johnson | 1 | $16 |
| Bayer | 1 | $16 |
| Merck | 1 | $16 |
| Bausch Health US, LLC | 1 | $15 |
How this compares
$1,964 in reported general payments places this provider in the 70th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 17 | $22,184 |
| JanuviaSitagliptin Phosphate | 13 | $21,585 |
| TrulicityDulaglutide | 11 | $10,350 |
| EliquisApixaban | 11 | $8,466 |
| Spiriva RespimatTiotropium Bromide | 13 | $6,588 |
| Humulin N KwikpenInsulin Nph Human Isophane | 11 | $2,847 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $2,587 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 12 | $1,783 |
| Levothyroxine Sodium | 112 | $1,100 |
| Atorvastatin Calcium | 112 | $858 |
| Duloxetine Hcl | 35 | $767 |
| Trazodone Hcl | 51 | $741 |
| Telmisartan | 11 | $727 |
| Gabapentin | 37 | $673 |
| SynthroidLevothyroxine Sodium | 11 | $648 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Spiriva Respimat | $18 | $28,77230 claims |
| MerckJanuvia | $16 | $21,58513 claims |
| Lilly USA, LLCTrulicity | $171 | $10,35011 claims |
| PfizerEliquis | $25 | $8,46611 claims |
| AstraZenecaSymbicort | $130 | $2,58711 claims |
| AbbVieSynthroid | $566 | $64811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Other obstetrics & gynecology in Marietta
- David MontaldiMarietta$1.1M
- Teresa ByrdMarietta$41K
- Eduardo EstrellaMarietta$26K
- Jeffrey MarcusMarietta$12K
- Gretchen MitchellCumming$4.5M
- Stephen BlankAtlanta$3.5M
- Eric BrownAtlanta$1.7M
- Melissa KottkeAtlanta$1.7M
- Allan DinnersteinFort Stewart$1.5M
- Winifred SoufiAtlanta$889K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.